Gylden Pharma

Abingdon, United Kingdom

Pioneering a new approach to vaccine development and manufacturing using cutting-edge technologies to produce novel synthetic vaccines.

$667K raised

Feb 2022

Grant

Biopharma Biotechnology Health Care

Top Investors

Innovate UK Vickers Venture Partners Trend Investment Group Department of Health and Social Care

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Gylden Pharma

How much funding has Gylden Pharma raised?

Gylden Pharma has raised $667K in total funding. The most recent round was Grant. The last funding was announced in February 2022.

Who are Gylden Pharma's investors?

Gylden Pharma's investors include Innovate UK, Vickers Venture Partners, Trend Investment Group, Department of Health and Social Care.

Where is Gylden Pharma headquartered?

Gylden Pharma is headquartered in Abingdon, United Kingdom.

What does Gylden Pharma do?

Pioneering a new approach to vaccine development and manufacturing using cutting-edge technologies to produce novel synthetic vaccines.

What stage is Gylden Pharma at?

Gylden Pharma is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 22, 2022.

MLA

"Gylden Pharma — Funding & Investors." VCBacked, February 22, 2022, https://www.vcbacked.co/company/gylden-pharma. Accessed July 2, 2026.

APA

VCBacked. (2022). Gylden Pharma — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/gylden-pharma

Wikipedia (cite web)

{{cite web |title=Gylden Pharma — Funding & Investors |url=https://www.vcbacked.co/company/gylden-pharma |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 22, 2022.

Similar Companies in Biopharma

View all

Allterum Therapeutics

Living In Silico Inc.